ClinicalTrials.gg
Status unknownNCT03481621Acu/Vul-painUpdated Sep 3, 2020

Effect of Two Acupuncture Protocols on Vulvodynia

An interventional study of Acupuncture and Standard care in Vulvodynia, Vulvodynia, Generalized and Vulvar Vestibulitis, sponsored by McLean Center for Complementary and Alternative Medicine, PLC. Status unknown at 1 site in United States. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2020-09-03.

Sponsored by McLean Center for Complementary and Alternative Medicine, PLC · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 47 studies in Vulvodynia with a site in United States — 8 open to participants now, 9 under way, 1 of them phase 3. Vulvodynia · United States.

Planned enrollment
16th of 36
51 · median 45
Started
2018
with 6 others
No phase
18 of 47
1 open now
Registered
29th of 47
by date

Among the 47 studies in Vulvodynia with a site in United States, this one is the 16th largest by planned enrollment of the 36 interventional ones that give a count, is one of 7 that started in 2018, is one of 18 with no phase, and was the 29th registered.

Vulvodynia

117 studies on the registry are indexed under Vulvodynia; 21 are open to participants now.

Browse Vulvodynia studies →

Open to participants now

8 of the 47 studies in Vulvodynia with a site in United States are open now. Recruiting first, the newest first:

3 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 13 Vulvodynia studies recruiting now, 8 (62%) set no upper age limit and 5 (38%) stop at 75 or younger; 0 take children under 18; 2 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 47 studies in Vulvodynia with a site in United States, or all of them as a file.
02

Study summary

Vulvodynia is a common condition in women (16%); however, at this time there is no known effective non-pharmacological therapy reported. Acupuncture is one complementary and alternative medicine therapy used by many patients with vulvodynia; some case reports show that acupuncture may be an effective intervention. In recent years, there were some studies registered took at like at actual trials of acupuncture on vulvodynia, but either they did not reach the trial aims, some studies did not get enough patients or the trial designs mimic drug studies and did not reflect acupuncture real characteristics.

This study evaluates acupuncture for the treatment of vulvodynia; specifically, if it reduces vulvar pain, pain duration and pain with intercourse. It also examines how long the effect of acupuncture lasts in women with vulvodynia. One third of the women will receive acupuncture focused on pudendal nerve distribution area; another one third of the women will receive acupuncture focused on traditional meridian points; the other one third of women will use standard care (without acupuncture). Women who get a reduction in pain (included in subjective and objective scores) will have their pain monitored once a week for up to 6 weeks to see if the acupuncture effect lasts.

Read the detailed description

Aims of this study:

  1. Get preliminary data for future larger, randomized- controlled trials.
  2. See whether acupuncture is better than no-acupuncture treatments (where participations are following standard care for this condition), or at least have probable better outcomes than no acupuncture treatment (there may not be significance in statistics, given the small sample in current proposed trial);
  3. See if acupuncture group 1a (with focus on the points in pudendal nerve distribution near the pain area) has better results(at least, a trend) than acupuncture group 1b (traditional acupuncture focus on meridian or distal points).

The basic design and interventions:

  1. Diagnosis: Vulvodynia/Vulval pain by gynecologist or pain specialist/doctor, who will adopt International diagnose criteria.
  2. Patient sample (estimated): 17 in each acupuncture group (34 total), and 17 patients in the no-acupuncture group or standard care waiting list . Total 51 patients;
  3. Groups:

    Group 1a (17 cases): acupuncture, using the local points in pudendal nerve distribution area (tender points, and up to two other set of acupuncture points); Group 1b (17 cases): traditional acupuncture, using common meridian or distal points; Group 2 (17 cases): standard care, waiting list. This group will receive no acupuncture treatment.

  4. Randomized method: If the patient feels comfortable with acupuncture, they will be randomly assigned to either Group 1a or Group1b using randomization numbers generated by computer; if the patients still are under the treatments of routine conventional treatments, such as using pain medications, local injections, and physical therapies, or other non-surgical procedure, they will serve as participants in the standard care group, the waiting list.
  5. Blind Method: Patients will be blind as to the purpose of the study as well as to the groups that they are assigned too. Each participant in either group 1a or 1b will receive actual, real acupuncture treatment but, depending on their group assignment, the strategy and points used will vary.
  6. Treatments:

    Group 1a: acupuncture: needling focus on Hui yang, pudendal nerve points and local point(s) near the pain location with needling manipulation (such as twisting 200/min for 2-5 minutes at pudendal nerve points); Group 1b: acupuncture: using meridian points, focus on Xue Hai (SP9), San Yin Jiao (SP6), Zu San Li (ST36); Both groups also use: Shen Ting (GV24), Tou Wei (ST 8), Yin Tang (EX2) for helping to release stress and create calm.

    Both group 1(a/b) and group 2 patients are all allowed to use pain medications (in which the medications' name and how many pills used during 6 weeks' observation period will be carefully document); the standard care group actually is a waiting list, without acupuncture intervention. Follow up: 6 weeks.

    Acupuncture time and frequency: 45 min per session, once or twice per week, for 6-12 sessions (in 6 weeks).

  7. Main observation:

(1) Objective pain score(tested using cotton swab); (2) Patient self reported pain score (subjective, before Cotton swab test); Others: Pain duration and pain score during intercourse.

  1. Statistics: student t-test.

Sample calculation: The expected difference (ECSD) between two means is 3, and the common within group standard deviation is 3. Giving an 80 chance that an 0.05 level test of significance will find a statistically significant difference between two sample means are compared, the sample size is approximately 17 per group.

Comparisons:

  1. At the end point (end of 6 weeks), make comparisons between acupuncture (1a+1b) group and group 2, acupuncture 1a and group 2, acupuncture 1b and group 2; between acupuncture 1a and acupuncture 1b; respectively.
  2. At the end point (end of 6 weeks), make comparisons in each group self (before and after).
03

Conditions studied

  • Vulvodynia
  • Vulvodynia, Generalized
  • Vulvar Vestibulitis
  • Vulvar Pain

Keywords

  • Vulvodynia
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. diagnosis of generalized vulvodynia or provoked vestibulodynia by OB/GYN doctor(s) or pain specialist(s); 18 to 45 years old.
  2. Current pain score 4 or higher with tampon insertion and removal performed, or cotton swab test, at the initial screening exam
  3. speak and read English or Chinese.

Exclusion criteria

Exclusion Criteria:

  1. infectious conditions of the vulvar/vagina;
  2. inflammatory conditions of the vulvar/vagina;
  3. neoplastic disorders of the vulvar/vagina;
  4. neurologic disorders of the vulvar/vagina;
  5. acute trauma to the genitals;
  6. iatrogenic conditions of the genitals
  7. hormonal deficiencies
  8. co-morbid pelvic pain conditions (to avoid confounding pain outcomes) such as pelvic inflammatory disease and documented history of endometriosis
  9. menopause
  10. patients have active migraine headaches, temporomandibular joint disease (TMJ), irritable bowel syndrome (IBS), interstitial cystitis, painful bladder syndrome, or fibromyalgia, in past 6 month.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
51 participants (estimated)

Study arms

  • Active comparator
    Group1a, Acupuncture on Vulvodynia

    Focus on using the local points in pudendal nerve distribution area

    Device: Acupuncture

  • Active comparator
    Group1b, Acupuncture on Vulvodynia

    Focus on traditional acupuncture using common meridian or distal points

    Device: Acupuncture

  • Active comparator
    Group2, Standard care or waiting lists

    Standard care without acupuncture

    Other: Standard care

Interventions

  • DeviceAcupuncture

    Needle size: #32(0.22 mm), 1-1.5 inch(30-40 mm long); Acupuncture time and frequency: 45 min per session, once or twice per week, for 6-12 sessions total (in 6 weeks).

    Also known as: Needling

  • OtherStandard care

    PT, pain medications, nerve block, etc

    Also known as: Routine treatments

06

What researchers measure

Primary outcomes

  1. Pain Score (objective)

    Figure out the pain score using Visual Analog pain scale(VAS) using cotton swab , \[score 0-no pain, 10-strongest (unbearable) pain\]. Expected clinical significant difference (ECSD): 3.

    Time frame: at the end of 6 weeks

Secondary outcomes

  1. Pain Score (Subjective)

    Figure out the pain score using Visual Analog pain scale(VAS) before use of cotton swab to to test pain , \[score 0-no pain, 10-strongest (unbearable) pain\]. Expected clinical significant difference (ECSD): 3.

    Time frame: at the end of 6 weeks

  2. Pain duration

    Monitor the hours of pain per day

    Time frame: at the end of 6 weeks

  3. Intercourse pain

    Record how much pain during intercourse using Visual Analog pain scale(VAS) \[score 0-no pain, 10-strongest\]

    Time frame: at the end of 6 weeks

07

Study locations

1 of 1 sites recruiting
  • McLean Center for Complementary and Alternative Medicine,PLC
    Vienna, Virginia 22182, United States
    Recruiting
08

References and documents

Publications

  • Fan AY, Alemi SF, Zhu YH, Rahimi S, Wei H, Tian H, He D, Gong C, Yang G, He C, Ouyang H. Effectiveness of two different acupuncture strategies in patients with vulvodynia: Study protocol for a pilot pragmatic controlled trial. J Integr Med. 2018 Nov;16(6):384-389. doi: 10.1016/j.joim.2018.10.004. Epub 2018 Oct 10. PubMed 30341023 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2018 (actual). Primary completion is estimated for Dec 2020, 35 months after the start.

Of 32 non-industry interventional studies with no phase under Vulvodynia, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 56. This study's planned 35 months is close to that.

Counting every sponsor, half of 32 studies reached it within 36 months; a quarter within 16 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 8, 2018
First posted
Mar 29, 2018
StartActual
Jan 1, 2018
Primary completionEst.
Dec 31, 2020
CompletionEst.
Dec 31, 2021
Last update
Sep 3, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03481621
Lead sponsor
McLean Center for Complementary and Alternative Medicine, PLC
Responsible party
Arthur Fan (Director,Principal Investigator, McLean Center for Complementary and Alternative Medicine, PLC) — Principal investigator
First posted
Mar 29, 2018
Start date
Jan 1, 2018
Primary completion
Dec 31, 2020 (estimated)
Completion
Dec 31, 2021 (estimated)
Last update
Sep 3, 2020

Study contacts

Arthur Y Fan, MD(CHN),PhD
Contact
ArthurFan@ChineseMedicineDoctor.us
7034994428
Sarah F Alemi, DAc,LAc
Contact
ArthurFan@ChineseMedicineDoctor.us
7035478197
Arthur Y Fan, MD(CHN),PhD
principal investigator · McLean Center for Complementary and Alternative Medicine, PLC

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion